Fundraising Fox
Sherlock Biosciences
Cambridge, US · Founded 2018 · Delaware corporation · 432 employees on LinkedIn · 8 known investors
Find your way into Sherlock Biosciences
Each arrow is one introduction. Sign up to fill in the first one.
Ask Nick Naclerio to introduce you to David R. Walt
You →Nick · together at Quanterix →David
Ask Jamie Chen to introduce you to Rahul Dhanda
You →Jamie · together at Syntis Bio →Rahul
Ask Sam Okafor to introduce you to Jim J. Collins
You →Sam · together at Sherlock Biosciences →Jim
Sign up to find every way you can get introduced to Sherlock Biosciences
- Your email: who you already know at Sherlock Biosciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Sherlock Biosciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
Sherlock Biosciences was founded in 2018 by Rahul Dhanda, James Collins, and David Walt.
Board
Investors · 8
How we know: Catalio Capital Management, LP's portfolio page · Not right? Tell us
How we know: Illumina Ventures's portfolio page · prnewswire.com · funding news · the VCSheet dataset · Not right? Tell us
How we know: prnewswire.com · funding news · Not right? Tell us
How we know: prnewswire.com · funding news · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: prnewswire.com · funding news · Not right? Tell us
How we know: prnewswire.com · funding news · Not right? Tell us
Also in the syndicate · 1
Reported raises · per SEC filings
Form D private placements$112.8M disclosed across 2 rounds · 2019–2022
▶$80MraisedMar 2022 · 13 investors · Other Health CareRule 506(b)
- Michael RubinDirector
- Issi RozenDirector
- David WaltDirector
- James CollinsDirector
- Bryan DechairoExecutive Officer, Director
- Offering amount
- $80M
- Amount sold
- $80M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$32.8MraisedApr 2019 · 10 investors · Other Health CareRule 506(b)
- Rahul DhandaExecutive Officer, Director
- James CollinsDirector
- Issi RozenDirector
- David WaltDirector
- Offering amount
- $33.8M
- Amount sold
- $32.8M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Sherlock Biosciences went on to found or lead other companies.
Related companies · 1
Companies working in the same space as Sherlock Biosciences.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of Agriculture (USDA) | Phase I | 2023 | $175K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded Sherlock Biosciences?
- Sherlock Biosciences was founded by Rahul Dhanda, James Collins, David Walt in 2018.
- Who are Sherlock Biosciences's investors?
- Sherlock Biosciences's investors include Catalio Capital Management, LP, Illumina Ventures, Catalio Capital Management, Good Ventures, GV (Google Ventures), Northpond Ventures, Novalis LifeSciences.
- How much funding has Sherlock Biosciences raised?
- Sherlock Biosciences has disclosed $112.8M raised across 2 rounds.
- Where is Sherlock Biosciences headquartered?
- Sherlock Biosciences is headquartered in Cambridge, US.